Risk stratification in hypertrophic cardiomyopathy

peer reviewedHypertrophic cardiomyopathy is of genetic origin, characterized by asymmetric left ventricular hypertrophy and variable clinical presentation. The physiopathology includes diastolic dysfunction and, in one third of the patients, dynamic left ventricular outflow tract obstruction. Patients are at increased risk of sudden death. Risk stratification in the individual patient is an essential component of management. This article describes the clinical presentation of a patient and his mother and summarizes essential features of the disease and the current recommendations for the prevention of sudden cardiac death

Efficacité et tolérance des injections de Juvéderm® Voluma, acide hyaluronique hautement réticulé, dans la prise en charge des énophtalmies et des rétractions palpébrales

PARIS7-Xavier Bichat (751182101) / SudocPARIS-Bib. Serv.Santé Armées (751055204) / SudocSudocFranceF

Clinical Case of the Month. Prolapse Due to Fibro-Elastic Degeneration. The Aging of the Mitral Valve

peer reviewedWe report the case of a 73-year-old woman who presents an acute mitral regurgitation secondary to fibro-elastic degenerescence. A mitral valvuloplasty is rapidly performed with complete disappearance of valvular insufficiency and the patient leaves the hospital ten days later. Degenerative mitral regurgitation is commonly seen in elderly patients. This constitutes an excellent indication for mitral valvuloplasty, rather than valve replacement. In our experience, mitral valvuloplasty leads to a complete correction of valvular regurgitation without neither stenosis, nor subvalvular obstruction. Left ventricular function is preserved, as subvalvular apparatus is conserved. This approach allows, in the absence of specific indication, anticoagulation withdrawn two to three months later